Dr. David Pisetsky curated the research presented at ACR Convergence 2025 and answers the question “What new research on psoriatic arthritis has the potential to impact patient care or future research?”
The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on SLE and lupus nephritis, inflammatory brain diseases, drug management of rheumatic diseases and mimics of inflammatory myopathies.
The ACR honors excellence in rheumatology. Meet the 2025 Awards of Distinction recipients, ACR Masters & Distinguished Fellows recognized at ACR Convergence 2025.
New research presented at ACR Convergence 2025 highlights how the Rheumatology Informatics System for Effectiveness (RISE) Registry—the nation’s largest collection of electronic health record data from rheumatology practices—is driving transformative improvements in quality, safety and outcomes in patients with rheumatic and musculoskeletal diseases. Research studies reveal that participation in and engagement with RISE not only…
Preparing for ACR Convergence 2025 is easy with the dedicated mobile app—your essential companion for a seamless meeting experience. Available for download on the Apple App Store and Google Play, the ACR Convergence 2025 app puts all the information you need right at your fingertips. Once downloaded, log in with the email and password you…
Urine biomarkers have the potential to change how lupus nephritis is managed, serving as a noninvasive means of early detection, assessing treatment response and more.